SA55 nasal spray
PRO-SA55-1002
Phase 1 small_molecule active
Quick answer
SA55 nasal spray for COVID-19 is a Phase 1 program (small_molecule) at SINOVAC BIOTECH LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- SINOVAC BIOTECH LTD
- Indication
- COVID-19
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active